Clinical trials in Morristown, NJ

32 recruiting studies have a site in or near Morristown, NJ, New Jersey.

Top conditions here

All conditions

Showing 32 of 32 studies

RecruitingPhase 3NCT06345729

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Sponsor: Merck Sharp & Dohme LLC

Morristown, NJ · +14 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Hackensack, NJ · Morristown, NJ · New Brunswick, NJ · +112 more sites

RecruitingPhase 3NCT07071519

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Sponsor: AbbVie

Morristown, NJ · +11 more sites

RecruitingPhase 3NCT06405087

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Sponsor: Takeda

Morristown, NJ · +12 more sites

RecruitingPhase 3NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Sponsor: Eli Lilly and Company

Morristown, NJ · +14 more sites

RecruitingPhase 3NCT05711394

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Sponsor: AbbVie

Morristown, NJ · +41 more sites

RecruitingNot applicableNCT07069738

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

Sponsor: Boston Scientific Corporation

Morristown, NJ · +41 more sites

RecruitingNot applicableNCT03523416

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

Sponsor: Edwards Lifesciences

Morristown, NJ · +18 more sites

RecruitingPhase 1NCT07085091

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Sponsor: ALX Oncology Inc.

Morristown, NJ · +11 more sites

RecruitingPhase 3NCT05923073

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC

Morristown, NJ · +13 more sites

RecruitingPhase 3NCT05995353

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Sponsor: AbbVie

Morristown, NJ · +10 more sites

RecruitingPhase 3NCT06561386

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Sponsor: Bristol-Myers Squibb

Morristown, NJ · Paterson, NJ · +54 more sites

RecruitingPhase 1 / Phase 2NCT06445062

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Sponsor: Revolution Medicines, Inc.

Morristown, NJ · +31 more sites

RecruitingPhase 1 / Phase 2NCT07262619

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Sponsor: Eikon Therapeutics

Morristown, NJ · +9 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Hackensack, NJ · Morristown, NJ · Neptune City, NJ · +183 more sites

RecruitingPhase 3NCT05125302

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Sponsor: AbbVie

Annandale, NJ · Morristown, NJ · Runnemede, NJ · +122 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +1223 more sites

RecruitingPhase not listedNCT02418442

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Sponsor: Duke University

Hackensack, NJ · Morristown, NJ · New Brunswick, NJ · +72 more sites

RecruitingPhase not listedNCT06388421

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: United Therapeutics

Morristown, NJ · Neptune City, NJ · +68 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Hackensack, NJ · Morristown, NJ · Neptune City, NJ · +161 more sites

RecruitingPhase not listedNCT00271180

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Sponsor: Medtronic

Eatontown, NJ · Marlton, NJ · Morristown, NJ · +110 more sites

RecruitingPhase not listedNCT05489705

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Sponsor: Bristol-Myers Squibb

Hackensack, NJ · Morristown, NJ · +58 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +825 more sites

RecruitingPhase 3NCT06100289

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Sponsor: Takeda

Morristown, NJ · +13 more sites

RecruitingPhase 4NCT07614321

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

Sponsor: Atlantic Health System

Morristown, NJ

RecruitingPhase 4NCT05781152

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Sponsor: Connecticut Children's Medical Center

Morristown, NJ · +21 more sites

RecruitingPhase 3NCT05442567

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Sponsor: Takeda

Morristown, NJ · +21 more sites

RecruitingPhase 3NCT04779320

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Sponsor: Takeda

Morristown, NJ · +21 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Basking Ridge, NJ · Middletown, NJ · Montvale, NJ · +809 more sites

RecruitingPhase 1 / Phase 2NCT04988555

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Sponsor: Sumitomo Pharma America, Inc.

Morristown, NJ · New Brunswick, NJ · +31 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Cherry Hill, NJ · Englewood, NJ · Moorestown, NJ · +952 more sites

Not yet recruitingPhase 1NCT07873931

A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases

Sponsor: Bristol-Myers Squibb

Morristown, NJ · +10 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.